Petros Pharmaceuticals PTPI
OTC PTPI
$0.00 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Petros Pharmaceuticals, Inc. (PTPI) Income from Continuing Operations (2020 - 2026)

Updated

Petros Pharmaceuticals (PTPI) reported Income from Continuing Operations of -$955,625 for Q2 2026, compared with -$2.04 million a year earlier.

Analysis

Petros Pharmaceuticals, Inc. (PTPI) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Petros Pharmaceuticals' Income from Continuing Operations came in at -$3.2 million; for FY2025, it was -$4.5 million.

  • By year, Income from Continuing Operations came in at -$705,174 in FY2024, -$8.16 million in FY2023, -$20.04 million in FY2022 and -$8.99 million in FY2021.
  • Five-year quarterly Income from Continuing Operations spans a low of -$13.83 million in Q3 2022 and a high of $384,288 in Q2 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$987,036 (Q1 2026), -$336,506 (Q4 2025) and -$922,723 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -955,625.00
Mar 31, 2026 -987,036.00
Dec 31, 2025 -336,506.00
Sep 30, 2025 -922,723.00
Jun 30, 2025 -2.04 Mn
Mar 31, 2025 -1.20 Mn
Dec 31, 2024 -552,813.00
Sep 30, 2024 -919,541.00
Jun 30, 2024 384,288.00
Mar 31, 2024 382,893.00
Dec 31, 2023 318,150.00
Sep 30, 2023 -4.55 Mn
Jun 30, 2023 -2.55 Mn
Mar 31, 2023 -1.39 Mn
Dec 31, 2022 -4.23 Mn
Sep 30, 2022 -13.83 Mn
Jun 30, 2022 -1.81 Mn
Mar 31, 2022 -481,198.00
Dec 31, 2021 -8.19 Mn
Sep 30, 2021 -1.70 Mn
API Access

Petros Pharmaceuticals, Inc. Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=PTPI&period=max&api_key=YOUR_API_KEY